868.62MMarket Cap-4753P/E (TTM)
11.440High10.710Low5.27MVolume10.890Open10.750Pre Close58.13MTurnover9.77%Turnover RatioLossP/E (Static)77.76MShares24.17052wk High2.05P/B602.30MFloat Cap9.68052wk Low--Dividend TTM53.92MShs Float43.000Historical High--Div YieldTTM6.79%Amplitude2.500Historical Low11.038Avg Price1Lot Size
Kura Oncology Stock Forum
Kura Oncology Announces Publication of Ziftomenib Phase 1 Results in The Lancet Oncology | KURA Stock News
$Kura Oncology (KURA.US)$
No comment yet